Pain With Trigger Finger Injection: A Comparison of Steroid Alone Versus Steroid/Lidocaine Mixture

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE4

Total Enrollment

26 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-06-30

Study Completion Date

2017-01-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This research is being done to compare pain relief and efficacy of trigger finger injection using a combination of lidocaine/corticosteroid versus corticosteroid injection alone versus corticosteroid/saline combination.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

TPI Medication Comparison - Ketorolac, Lidocaine, or Dexamethasone

NCT03028012

Myofascial Pain

TERMINATED PHASE4

Corticosteroid(CS) + Lido or Corticosteroid(CS) Alone

NCT03704584

Tenosynovitis

TERMINATED PHASE4

The Efficacy of Local Anesthetics to Reduce Shoulder Pain Post-Steroid Injections

NCT02592629

Shoulder Pain

TERMINATED PHASE4

Treatment Efficacy of Local Anesthetic/Steroid Mixture Injection for Patients With Odynophonia

NCT05178485

Patients With a Diagnosis of Odynophonia

WITHDRAWN PHASE4

The SToICAL Study - The Soft Tissue Injection of Corticosteroid And Local Anaesthetic Study

NCT04253457

Carpal Tunnel Syndrome De Quervains Tenosynovitis Trigger Finger

SUSPENDED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective, randomized study comparing pain relief and efficacy of trigger finger injection using a combination of lidocaine/corticosteroid versus corticosteroid injection alone versus corticosteroid/saline combination.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Trigger Finger Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Corticosteroid alone (CS) Group

1 cc dexamethasone sodium phosphate (4mg/ml) injectable

Group Type ACTIVE_COMPARATOR

Dexamethasone Sodium Phosphate

Intervention Type DRUG

adreno-cortical steroid anti-inflammatory drug

Corticosteroid/Lidocaine (CSL) Group

1 cc dexamethasone sodium phosphate (4 mg/ml) injectable and 1 cc 1% Xylocaine (lidocaine) injectable

Group Type ACTIVE_COMPARATOR

Dexamethasone Sodium Phosphate

Intervention Type DRUG

adreno-cortical steroid anti-inflammatory drug

Xylocaine

Intervention Type DRUG

a local anesthetic agent

Corticosteroid/Saline (CSS) Group

1 cc dexamethasone sodium phosphate (4mg/ml) injectable and 1 cc 0.9% injectable Sodium Chloride (saline)

Group Type ACTIVE_COMPARATOR

Dexamethasone Sodium Phosphate

Intervention Type DRUG

adreno-cortical steroid anti-inflammatory drug

Sodium Chloride

Intervention Type DRUG

Sodium chloride is a sterile, nonpryogenic solution for fluid and electrolyte replenishment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dexamethasone Sodium Phosphate

adreno-cortical steroid anti-inflammatory drug

Intervention Type DRUG

Xylocaine

a local anesthetic agent

Intervention Type DRUG

Sodium Chloride

Sodium chloride is a sterile, nonpryogenic solution for fluid and electrolyte replenishment

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Decadron phosphate Lidocaine HCL Saline

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18-90
* Male or female (non-pregnant)
* Clinically diagnosed trigger digit
* Subject is able to provide voluntary, written informed consent
* Subject, in the opinion of the clinical investigator, is able to understand the clinical investigation and is willing to perform all study procedures and follow-up visits.

Exclusion Criteria

* Age \<18 or \>90
* Pregnant or lactating women
* Non-English speaking individuals
* Medication contradictions to lidocaine, corticosteroids and/or saline
* Prior injection or surgery on the affected finger
* Diagnosis of reflex symptomatic dystrophy (RSD) or complex regional pain syndrome (CRPS)
* Open wound

Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No